ORGO — Organogenesis Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Organogenesis Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	84.4	114	102	104	136
Net Total Accounts Receivable
Net Total Receivables	56.8	82.5	89.5	82	110
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	174	227	223	225	286
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	60.1	128	146	156	126
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	294	443	449	460	498
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	68.2	82	75	80.5	77.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	148	201	184	181	113
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	146	242	266	279	385
Total Liabilities & Shareholders' Equity	294	443	449	460	498
Total Common Shares Outstanding
Total Preferred Shares Outstanding